SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aventis Pharma board will approve financial results

07 Jul 2012 Evaluate
Aventis Pharma has informed that a meeting of the board of directors of the company will be held on July 25, 2012, for approving the unaudited financial results for the quarter and half year ended June 30, 2012 and for considering the question of declaring an interim dividend for the current financial year ending on December 31, 2012.

The above information is a part of company's filings submitted to BSE.

Sanofi India Share Price

3410.60 55.15 (1.64%)
10-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1935.25
Dr. Reddys Labs. 1245.50
Cipla 1438.75
Zydus Lifesciences 1150.50
Lupin 2496.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: